Philip Morris shares rise amid bullish outlook on Zyn products
Philip Morris International Inc shares have increased by 3.01%, reaching a 20-day high, despite the broader market decline with the Nasdaq-100 down 1.64% and the S&P 500 down 0.94%.
The rise in Philip Morris's stock is attributed to a growing investor interest in the company's Zyn oral nicotine pouches, which have gained traction in the U.S. market. This bullish sentiment comes as the company has seen a significant 44% increase in its shares over the past year, reflecting confidence in its non-cyclical defensive stock appeal amid a challenging economic environment.
This performance indicates that investors are favoring companies like Philip Morris that are innovating in the nicotine space, even as the overall consumer staples sector faces headwinds. The positive outlook on Zyn products suggests potential for continued growth and resilience in the company's stock price.
Trade with 70% Backtested Accuracy
Analyst Views on PM
About PM
About the author

- Profit Forecast Cut: Philip Morris CEO Jacek Olczak announced a reduction in the annual profit forecast due to margin pressures stemming from rising energy costs linked to the Iran conflict and currency fluctuations, indicating challenges as consumers tighten spending.
- Regulatory Environment Improvement: Speaking at the Deutsche Bank global consumer conference, Olczak noted that recent FDA moves to relax enforcement on unauthorized vaping and nicotine pouches are a 'net positive,' which not only reduces regulatory uncertainty for Zyn but should also support category growth.
- Stock Price Movement: Shares of Philip Morris fell about 1% before the market opened, reflecting investor concerns regarding the company's outlook, particularly in light of the lowered profit forecast, which may impact market confidence.
- Market Reaction Analysis: Despite facing profit pressures and stock declines, Olczak's comments suggest a positive outlook for future growth, especially with the improved regulatory environment potentially providing opportunities for market expansion of new products.
- Current Illicit Consumption: A recent KPMG study reveals that illicit cigarette consumption in the EU is projected to reach 10.3% of total consumption by 2025, resulting in an estimated €16.7 billion tax revenue loss, highlighting significant challenges in combating illicit trade in the region.
- Market Impact Analysis: Across 38 European countries, illicit consumption amounts to 55.3 billion cigarettes, leading to approximately €22.4 billion in state budget revenue losses, indicating the severe impact of illicit trade on the entire tobacco and nicotine value chain.
- Surge in Counterfeits: The consumption of counterfeit cigarettes is expected to hit 18.3 billion in 2025, accounting for 44% of illicit consumption and reflecting a year-on-year increase of over 20%, which not only exacerbates market chaos but also poses a direct threat to legitimate businesses.
- Characteristics of the French Market: France has emerged as the largest illicit cigarette market in Europe, with an illicit share of 41.4%, equating to 20.5 billion cigarettes, of which counterfeits account for nearly 9.7 billion, illustrating the negative effects of excessive taxation and product bans on market dynamics.
- Rating Upgrade: Philip Morris International (PM) has received an 'overweight' rating, indicating analysts' optimistic outlook on its future performance, which may attract more investor interest.
- Price Target Set: Analysts have set an average price target of $194.4 for the company, reflecting the market's potential for stock appreciation, which could drive the stock price higher.
- Market Reaction Anticipation: The rating upgrade and price target increase may enhance investor confidence, thereby improving the liquidity and market performance of the company's stock, further solidifying its leadership position in the tobacco industry.
- Long-Term Growth Potential: With the company's ongoing investments in new products and market expansion, the analysts' positive rating may signal Philip Morris International's future growth potential and profitability.
- Chevron's Strong Performance: Chevron's stock has risen 25.6% over the past six months, slightly below the industry's 27.1% gain, benefiting from higher oil prices and quality assets from the Hess acquisition, with production growth guidance of 7%-10% enhancing cash flow and market competitiveness.
- Goldman's Robust Growth: Goldman Sachs shares have increased by 28.3% in the past six months, significantly outperforming the industry's 2.7% growth, with earnings exceeding estimates for four consecutive quarters, as management focuses on sustainable revenue streams and diversifies through private equity market expansion.
- Philip Morris's Successful Transition: Philip Morris's stock has gained 16% over the last six months, surpassing the tobacco industry's 11.8% growth, with Q1 net revenues up 9.1% year-over-year, driven by smoke-free products contributing 43% of total revenues, indicating strong growth potential in this segment.
- Optimistic Market Outlook: Zacks' stock-picking strategies have outperformed the S&P's average gain of 7.7% annually since 2000, with the latest recommendations of seven stocks expected to provide early price pop opportunities, reflecting Zacks' strong analytical capabilities and investment confidence.
- Illicit Market Scale: In 2025, illicit cigarette consumption in the EU reached 41.8 billion cigarettes, accounting for 10.3% of total consumption, resulting in an estimated €16.7 billion in lost tax revenues, highlighting the severity of the issue and its impact on public finances.
- Counterfeit Dominance: Counterfeit cigarettes now represent 44% of the illicit market, totaling 18.3 billion cigarettes, with a year-on-year increase exceeding 20%, indicating organized crime's rapid adaptation in production and distribution, exacerbating regulatory challenges.
- Western Europe Pressure: France, Belgium, and the Netherlands are the most affected countries, with France's illicit share at 41.4%, significantly increasing enforcement difficulties and imposing substantial fiscal pressures on the state.
- Policy Response Recommendations: Philip Morris International calls for evidence-based coordinated responses to strengthen law enforcement and public-private cooperation, aiming to mitigate the impact of illicit trade through balanced regulation.
- EPS Guidance Cut: Philip Morris has revised its 2026 full-year reported diluted EPS guidance to a range of $7.18 to $7.33, down from previous estimates, primarily due to a $500 million non-cash impairment charge at its Canadian affiliate.
- Adjusted Earnings Growth: Excluding a total adjustment of $1.13 per share, the forecast for adjusted diluted EPS is set at $8.31 to $8.46, representing a projected increase of 10.2% to 12.2% compared to $7.54 in 2025, indicating resilience amid challenges.
- Currency Impact Analysis: Driven by a stronger Russian ruble, Philip Morris anticipates a $0.20 per share unfavorable currency impact, yet expects overall revenue to reach $43.50 billion, showcasing the company's adaptability in global markets.
- Canadian Subsidiary Impairment: PMI's Canadian affiliate, RBH, is expected to record a non-cash impairment charge of approximately $500 million in Q2 2026, reflecting changes in industry dynamics, while its remaining carrying value is estimated to be less than $100 million.











